FDMT
Price
$25.67
Change
+$0.09 (+0.35%)
Updated
May 16, 6:59 PM EST
83 days until earnings call
SCPH
Price
$4.82
Change
+$0.25 (+5.47%)
Updated
May 16, 6:59 PM EST
82 days until earnings call
Ad is loading...

FDMT vs SCPH

Header iconFDMT vs SCPH Comparison
Open Charts FDMT vs SCPHBanner chart's image
4D Molecular Therapeutics
Price$25.67
Change+$0.09 (+0.35%)
Volume$303.45K
CapitalizationN/A
scPharmaceuticals
Price$4.82
Change+$0.25 (+5.47%)
Volume$232.23K
CapitalizationN/A
View a ticker or compare two or three
FDMT vs SCPH Comparison Chart

Loading...

FDMTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SCPHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
VS
FDMT vs. SCPH commentary
May 17, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FDMT is a Hold and SCPH is a Buy.

COMPARISON
Comparison
May 17, 2024
Stock price -- (FDMT: $25.64 vs. SCPH: $4.82)
Brand notoriety: FDMT and SCPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: FDMT: 90% vs. SCPH: 140%
Market capitalization -- FDMT: $1.32B vs. SCPH: $173.96M
FDMT [@Biotechnology] is valued at $1.32B. SCPH’s [@Biotechnology] market capitalization is $173.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $592.14B to $0. The average market capitalization across the [@Biotechnology] industry is $2.75B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

FDMT’s FA Score shows that 0 FA rating(s) are green whileSCPH’s FA Score has 0 green FA rating(s).

  • FDMT’s FA Score: 0 green, 5 red.
  • SCPH’s FA Score: 0 green, 5 red.
According to our system of comparison, FDMT is a better buy in the long-term than SCPH.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

FDMT’s TA Score shows that 3 TA indicator(s) are bullish while SCPH’s TA Score has 4 bullish TA indicator(s).

  • FDMT’s TA Score: 3 bullish, 5 bearish.
  • SCPH’s TA Score: 4 bullish, 3 bearish.
According to our system of comparison, SCPH is a better buy in the short-term than FDMT.

Price Growth

FDMT (@Biotechnology) experienced а 0.00% price change this week, while SCPH (@Biotechnology) price change was +0.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.45%. For the same industry, the average monthly price growth was +4.26%, and the average quarterly price growth was +63.16%.

Reported Earning Dates

FDMT is expected to report earnings on Aug 08, 2024.

SCPH is expected to report earnings on Aug 07, 2024.

Industries' Descriptions

@Biotechnology (+2.45% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for FDMT with price predictions.
OPEN
A.I.dvisor published
a Summary for SCPH with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
FDMT($1.32B) has a higher market cap than SCPH($174M). FDMT YTD gains are higher at: 26.555 vs. SCPH (-23.046).
FDMTSCPHFDMT / SCPH
Capitalization1.32B174M760%
EBITDAN/AN/A-
Gain YTD26.555-23.046-115%
P/E RatioN/AN/A-
RevenueN/AN/A-
Total CashN/AN/A-
Total DebtN/AN/A-
FUNDAMENTALS RATINGS
SCPH: Fundamental Ratings
SCPH
OUTLOOK RATING
1..100
25
VALUATION
overvalued / fair valued / undervalued
1..100
60
Fair valued
PROFIT vs RISK RATING
1..100
78
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
63
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
FDMTSCPH
RSI
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
Stochastic
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
75%
Momentum
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
74%
MACD
ODDS (%)
Bullish Trend 1 day ago
77%
Bullish Trend 1 day ago
79%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
78%
Bullish Trend 1 day ago
79%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 11 days ago
80%
Bullish Trend 1 day ago
80%
Declines
ODDS (%)
Bearish Trend 9 days ago
89%
Bearish Trend 5 days ago
83%
BollingerBands
ODDS (%)
N/A
Bearish Trend 1 day ago
85%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
88%
View a ticker or compare two or three
Ad is loading...
FDMTDaily Signal changed days agoGain/Loss if shorted
 
Show more...
SCPHDaily Signal changed days agoGain/Loss if shorted
 
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FLIIX11.190.04
+0.36%
First Sentier Global Listed Infras I
GCGIX32.03N/A
N/A
Goldman Sachs Large Cap Gr Insghts Instl
GCSIX28.81N/A
N/A
Goldman Sachs Small Cap Eq Insghts Instl
NSFOX10.64-0.03
-0.28%
Natixis Sustainable Future 2065 N
FKACX33.87-0.15
-0.44%
Franklin Growth Opportunities C

FDMT and

Correlation & Price change

A.I.dvisor indicates that over the last year, FDMT has been loosely correlated with MOR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if FDMT jumps, then MOR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To FDMT
1D Price
Change %
FDMT100%
+0.23%
MOR - FDMT
40%
Loosely correlated
+4.54%
KPTI - FDMT
39%
Loosely correlated
+0.44%
ORMP - FDMT
38%
Loosely correlated
-2.51%
SCPH - FDMT
38%
Loosely correlated
+5.58%
FOLD - FDMT
35%
Loosely correlated
-1.66%
More

SCPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, SCPH has been loosely correlated with NTLA. These tickers have moved in lockstep 46% of the time. This A.I.-generated data suggests there is some statistical probability that if SCPH jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SCPH
1D Price
Change %
SCPH100%
+5.58%
NTLA - SCPH
46%
Loosely correlated
-0.19%
BEAM - SCPH
42%
Loosely correlated
-1.33%
XNCR - SCPH
41%
Loosely correlated
+5.50%
PRME - SCPH
41%
Loosely correlated
+4.14%
PCVX - SCPH
40%
Loosely correlated
+5.33%
More